Pfizer increases prices in the US for the second time this year

The largest standalone drug maker in the US, announced it increase the prices of around 100 drugs for the second time this year, despite president Donald Trump’s pledge to slash the cost of drugs and treatments. The Financial Times reported on Monday that Pfizer upped the prices of prescription drugs including widely used lung-cancer treatment Xalkori, Norvasc blood-pressure pills, Lyrica pain capsules, and erectile dysfunction pill Viagra. The average 9.4% increase, effective as of 1 July, is the second time Pfizer decided to change prices this year after a double-digit rise about seven months ago.